{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:43:48Z","timestamp":1761468228418,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["K18006"],"award-info":[{"award-number":["K18006"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017104","name":"Yokohama City University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017104","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.tube.2008.12.004","type":"journal-article","created":{"date-parts":[[2009,2,11]],"date-time":"2009-02-11T22:40:41Z","timestamp":1234392041000},"page":"136-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Screening of tuberculosis by interferon-\u03b3 assay before biologic therapy for rheumatoid arthritis"],"prefix":"10.1016","volume":"89","author":[{"given":"Shuji","family":"Murakami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mistuhiro","family":"Takeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Kirino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reikou","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Ihata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhisa","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Watanuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Ishigatsubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2008.12.004_bib1","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra032906","article-title":"New drugs for rheumatoid arthritis","volume":"350","author":"Olsen","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tube.2008.12.004_bib2","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1186\/ar1994","article-title":"Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists","volume":"8","author":"Hamdi","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.tube.2008.12.004_bib3","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1002\/art.21137","article-title":"Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden","volume":"52","author":"Askling","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.tube.2008.12.004_bib4","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","article-title":"Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report","volume":"48","author":"Gomez-Reino","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.tube.2008.12.004_bib5","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tube.2008.12.004_bib6","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/art.20009","article-title":"Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy","volume":"50","author":"Wolfe","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.tube.2008.12.004_bib7","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1002\/art.21382","article-title":"Tuberculosis associated with therapy against tumor necrosis factor alpha","volume":"52","author":"Winthrop","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.tube.2008.12.004_bib8","first-page":"201","article-title":"Recommendations to lower the risk of tuberculosis in patients treated with tumour necrosis factor alpha antagonists","volume":"31","author":"Gomez-Reino","year":"2006","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.tube.2008.12.004_bib9","first-page":"247","article-title":"Tuberculosis in rheumatic patients treated with tumour necrosis factor alpha antagonists: the Portuguese experience","volume":"31","author":"Fonseca","year":"2006","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.tube.2008.12.004_bib10","first-page":"1127","article-title":"Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis","volume":"10","author":"Sichletidis","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2008.12.004_bib11","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1479-8077.2006.00198.x","article-title":"The efficacy of infliximab for patients with rheumatoid arthritis in Japan: results of 5000 cases by post-marketing surveillance data","volume":"9","author":"Oka","year":"2006","journal-title":"APLAR J Rheumatol"},{"key":"10.1016\/j.tube.2008.12.004_bib12","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0140-6736(06)68579-6","article-title":"Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study","volume":"367","author":"Ferrara","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2008.12.004_bib13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1473-3099(04)01206-X","article-title":"Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review","volume":"4","author":"Pai","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tube.2008.12.004_bib14","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1378\/chest.06-2471","article-title":"Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy","volume":"131","author":"Lalvani","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.tube.2008.12.004_bib15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/iai.64.1.16-22.1996","article-title":"Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG","volume":"64","author":"Harboe","year":"1996","journal-title":"Infect Immun"},{"issue":"Pt 11","key":"10.1016\/j.tube.2008.12.004_bib16","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1099\/00221287-144-11-3195","article-title":"A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10)","volume":"144","author":"Berthet","year":"1998","journal-title":"Microbiology"},{"key":"10.1016\/j.tube.2008.12.004_bib17","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1469-0691.2006.01391.x","article-title":"Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study","volume":"12","author":"Goletti","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.tube.2008.12.004_bib18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2249.2005.02884.x","article-title":"Diagnosis of Mycobacterium tuberculosis infection using ESAT-6 and intracellular cytokine cytometry","volume":"142","author":"Hughes","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.tube.2008.12.004_bib19","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/S0140-6736(04)17592-2","article-title":"Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study","volume":"364","author":"Liebeschuetz","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2008.12.004_bib20","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1128\/JCM.42.8.3469-3474.2004","article-title":"Selected pool of peptides from ESAT-6 and CFP-10 proteins for detection of Mycobacterium tuberculosis infection","volume":"42","author":"Scarpellini","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tube.2008.12.004_bib21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2334-6-66","article-title":"Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases","volume":"6","author":"Aiken","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.tube.2008.12.004_bib22","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1086\/382362","article-title":"Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia","volume":"38","author":"Hill","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tube.2008.12.004_bib23","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ard.2007.070789","article-title":"Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon {gamma} assay","volume":"67","author":"Matulis","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.tube.2008.12.004_bib24","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/art.23705","article-title":"Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy","volume":"59","author":"Chen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.tube.2008.12.004_bib25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/rheumatology\/kem351","article-title":"Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-{alpha} blocking drugs using a novel flow-cytometric interferon-{gamma} release assay","volume":"47","author":"Dinser","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.tube.2008.12.004_bib26","first-page":"775","article-title":"Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population","volume":"35","author":"Ponce de Leon","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.tube.2008.12.004_bib27","first-page":"683","article-title":"Tuberculosis associated with blocking agents against tumor necrosis factor-alpha \u2013 California, 2002\u20132003","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.tube.2008.12.004_bib28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/s10165-007-0626-3","article-title":"Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis","volume":"17","author":"Koike","year":"2007","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.tube.2008.12.004_bib29","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.cyto.2003.09.003","article-title":"Cytokine production profile in patients with Behcet's disease treated with infliximab","volume":"24","author":"Misumi","year":"2003","journal-title":"Cytokine"},{"key":"10.1016\/j.tube.2008.12.004_bib30","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1128\/IAI.68.2.990-993.2000","article-title":"MTSA-10, the product of the Rv3874 gene of Mycobacterium tuberculosis, elicits tuberculosis-specific, delayed-type hypersensitivity in guinea pigs","volume":"68","author":"Colangeli","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2008.12.004_bib31","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/s10165-004-0357-7","article-title":"Official Japanese guidelines for the use of infliximab for rheumatoid arthritis","volume":"15","author":"Miyasaka","year":"2005","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.tube.2008.12.004_bib32","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s10067-008-0867-3","article-title":"The evaluation of latent tuberculosis in rheumatologic diseases for anti-TNF therapy: experience with 192 patients","volume":"27","author":"Hanta","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.tube.2008.12.004_bib33","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3201\/eid0807.010506","article-title":"High risk for tuberculosis in hospital physicians, Peru","volume":"8","author":"Lima","year":"2002","journal-title":"Emerg Infect Dis"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979209000043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979209000043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:37:50Z","timestamp":1761467870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979209000043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1472979209000043"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2008.12.004","relation":{},"ISSN":["1472-9792"],"issn-type":[{"type":"print","value":"1472-9792"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening of tuberculosis by interferon-\u03b3 assay before biologic therapy for rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2008.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}